Handheld Ultrasound Developer Exo Raised $220M In Series C
Executive Summary
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
You may also be interested in...
Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
GE Healthcare Makes Entry Into Handheld Ultrasound Device Ring
GE Healthcare has announced the launch of Vscan Air, its first wireless ultrasound device.
Ultrasound Market To Bounce Back In 2021; Pandemic Will Accelerate Adoption Of New Tech
Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.